Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial.
在重大非心臟手術前持續使用與停止使用腎素-血管緊張素系統抑制劑:Stop-or-Not 隨機臨床試驗。
JAMA 2024-08-30
Adverse effects during treatment with renin-angiotensin-aldosterone system inhibitors; should we stay or should we stop?
使用腎素-血管收縮素-醛固酮系統抑制劑治療期間的不良反應:我們應該繼續還是停止?
Curr Opin Nephrol Hypertens 2023-09-17
Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis.
慢性腎臟病中止腎素-血管緊張素系統抑制劑與臨床結果:系統性回顧與荟萃分析。
Am J Nephrol 2023-11-01
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes.
停用腎素-血管緊張素-醛固酮系統抑制劑因高鉀血症導致較高的心腎結果。
Am J Nephrol 2023-11-09
Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease.
停用血管緊張素轉化酶抑制劑與血管緊張素受體拮抗劑比較在進展性慢性腎臟疾病中的評估(STOP ACEi 試驗)。
Kidney Int 2024-02-14
Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
慢性腎臟病患者接受經皮冠狀動脈介入治療後,腎素-血管緊張素系統抑制劑對二次預防的長期影響。
Kidney Dis (Basel) 2024-02-10
Association between Acute Declines in Estimated Glomerular Filtration Rate during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes.
腎素-血管緊張素系統抑制劑引起急性估計腎小球過濾率下降與不良結果風險之關聯。
J Am Soc Nephrol 2024-06-18
Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality.
停用後重新開始腎素-血管緊張素系統抑制劑對腎臟結果和死亡率的估計影響。
J Am Soc Nephrol 2024-06-18